Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

MBM Future Health

SME

mbm-futurehealth.comBerlin, Germany
4 profile visits

About

MBM Future Health, Access to Innovative Medicines

MBM Future Health offers strategic advice for international stakeholders on access to novel medicines.

Public Health and evidence-based decision-making have been the centre of my work for 20 years, almost 10 years at Germany’s top health policy body, the G-BA.

My particular focus for 15 years has been on rare diseases, including cell and gene therapies. A challenge I currently tackle is the use of real-world data, as well as the use of AI in clinical trials.

I am pleased to offer you strategic regulatory advice to ensure that patients get access to the best possible new medicines.

For rare diseases and other neglected diseases. Overall, for the best possible treatments in challenging indications.

Let's work together!

Social media

What is your business/industry sector?

Biotech, Pharma and CosmeticsHealthcare

Representatives

Meriem Bouslouk-Marx

HTA & Access Adviser

MBM Future Health

Marketplace (1)